← Leaderboards
Paul J Wolters
University Of California San Francisco
$9,235,001
Attributed
$9,235,001
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $799.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,235,001 · 5
By mechanism
R01$6,229,943 · 2
P01$2,093,103 · 1
K08$487,080 · 1
R21$424,875 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Alfred L Fisher$4,448,147
- Feroz R Papa$19,804,607
- Dean Sheppard$47,450,983
- Su Guo$23,174,473
- John V Fahy$35,378,030
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLungProteinsEpithelial CellsLung DiseasesAlveolar Type Ii CellFibrosisMediatingMesenchymalAlveolarPulmonary FibrosisPathway InteractionsHyperplasiaPlayMast CellGene ExpressionPhenotypeResponseGrowth FactorPathogenesisLinkPharmaceutical PreparationsIntegrinsPathologic
Grant awards (22)
Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II Cells$799,462
R01 · FY2025 · HL · contact PI
Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II Cells$783,378
R01 · FY2024 · HL · contact PI
Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II Cells$799,275
R01 · FY2023 · HL · contact PI
Lung fibrosis mediated by telomere dysfunction in alveolar type II cells$592,668
R01 · FY2021 · HL · contact PI
Lung fibrosis mediated by telomere dysfunction in alveolar type II cells$592,668
R01 · FY2020 · HL · contact PI
Lung fibrosis mediated by telomere dysfunction in alveolar type II cells$588,998
R01 · FY2019 · HL · contact PI
Lung fibrosis mediated by telomere dysfunction in alveolar type II cells$587,022
R01 · FY2018 · HL · contact PI
Human Cells and Tissues/Sheppard$696,687
P01 · FY2016 · HL · contact PI
Human Cells and Tissues/Sheppard$357,439
P01 · FY2015 · HL · contact PI
Human Cells and Tissues/Sheppard$345,404
P01 · FY2014 · HL · contact PI
Human Cells and Tissues/Sheppard$334,105
P01 · FY2013 · HL · contact PI
Human Cells and Tissues/Sheppard$359,468
P01 · FY2012 · HL · contact PI
Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung$193,125
R21 · FY2012 · HL · contact PI
Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung$231,750
R21 · FY2011 · HL · contact PI
Mast Cells and the Host Response in the Lung$359,123
R01 · FY2007 · HL · contact PI
Mast Cells and the Host Response in the Lung$369,849
R01 · FY2006 · HL · contact PI
Mast Cells and the Host Response in the Lung$378,750
R01 · FY2005 · HL
Mast Cells and the Host Response in the Lung$378,750
R01 · FY2004 · HL
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION$121,770
K08 · FY2003 · HL
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION$121,770
K08 · FY2002 · HL
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION$121,770
K08 · FY2001 · HL
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION$121,770
K08 · FY2000 · HL